SCHEMBL6916201

SCHEMBL6916201

O=S(=O)(Cc1ccccc1Cl)c1ccc2[nH]c(-c3cscn3)nc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 8/20 0.51
METAP2 P50579 5/20 0.51
CYP1A2 P05177 4/20 0.51
CYP3A4 P08684 4/20 0.51
CYP2C19 P33261 3/20 0.51
KDM4E B2RXH2 2/20 0.51
CYP2D6 P10635 2/20 0.51
NPC1 O15118 1/20 0.51
TP53 P04637 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
TSHR P16473 1/20 0.51
RAB9A P51151 1/20 0.51
FKBP1A P62942 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HIF1A Q16665 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1822351 0.85 CBFB (0.55) METAP1METAP2CYP1A2CYP3A4CYP2C19
SCHEMBL6915733 0.82 CYP2C9 (0.46) CYP1A2CYP3A4CYP2C19KDM4ECYP2D6
SCHEMBL6915839 0.81 CYP1A2 (0.44) CYP1A2CYP3A4CYP2C19KDM4ECYP2D6
SCHEMBL6925426 0.81 METAP1 (0.52) METAP1METAP2CYP1A2CYP3A4CYP2C19
SCHEMBL12689566 0.81 CYP2C9 (0.47) CYP1A2CYP3A4CYP2C19KDM4ECYP2D6
SCHEMBL12689481 0.80 GRM4 (0.42) METAP1CYP1A2CYP3A4CYP2C19KDM4E
SCHEMBL12689474 0.78 EGLN1 (0.38) CYP1A2CYP3A4CYP2C19KDM4ECYP2D6
SCHEMBL6915491 0.78 CBFB (0.54) METAP1METAP2CYP1A2CYP3A4CYP2C19
SCHEMBL6915101 0.77 CBFB (0.41) CYP1A2CYP3A4CYP2C19KDM4ECYP2D6
SCHEMBL21067822 0.77 CA12 (0.81) METAP1METAP2CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8912336-B2 Aryl and heteroaryl sulfones as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction VANDERBILT UNIVERSITY (US) 2014-12-16 US disclosed
WO-2011057208-A2 ARYL AND HETEROARYL SULFONES AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION VANDERBILT UNIVERSITY (US) 2011-05-12 WO disclosed